• Olpha will launch a new treatment for type 2 diabetes and weight management in the Baltics through a partnership with Adalvo.
• The agreement expands its diabetes portfolio, combining its Baltic sales infrastructure with Adalvo’s product development and supply capabilities.
• The treatment is expected to reach patients soon, strengthening the partners’ positions in the Baltic diabetes and obesity treatment market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AS Olpha published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.